Results of a new study suggest that remission of obesity-related complications in adolescents who underwent bariatric surgery is not dependent on sustained weight loss.
Americans with obesity and overweight are at greater risk for more severe COVID-19. Clinicians can support them best by asking how they can help.
Once-weekly semaglutide 2.0 mg vs 1.0 mg led to statistically significant, superior reductions in A1c and weight in type 2 diabetes patients not at goal, study finds.
Obesity, a complex chronic disease in itself, underlies many of the fatal cardiac and cardiometabolic diseases of the 21st century. Find a wide collection of expert guidance in this collection.
Video: Obesity expert Dr Louis Aronne outlines the role of medication in obesity treatment and says primary care is absolutely the place to begin.
Obese patients hospitalized with COVID-19 had lower levels of inflammation biomarkers but outcomes similar to non-obese patients with elevated levels of those biomarkers.
New research presented at ObesityWeek®2020 showed no statistical difference in severe COVID-19 outcomes between normal and obese patients.
Patients with obesity who utilized telemedicine services during quarantine achieved an average 2 kg weight loss, according to new research presented at the ObesityWeek®2020 virtual meeting.
Preventive Cardiology Collection Table of Contents: Expert video interviews, short, clinical guideline-focused quizzes, facts at-a-glance slideshows, plus news.
A longitudinal study of weight reduction in adolescents was redesigned to accommodate pandemic lockdown--and the results are very concerning.